balsam peru + benzyl benzoate + bismuth oxide + bismuth subgallate + hydrocortisone acetate + zinc oxide: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
balsam peru + benzyl benzoate + bismuth oxide + bismuth subgallate + hydrocortisone acetate + zinc oxide: clinical details
Prescribing considerations
- Confirm the diagnosis in persistent or recurrent anorectal symptoms.
- Investigate rectal bleeding or blood in the stool before treatment.
- Minimise prolonged or excessive exposure because rectal hydrocortisone can be absorbed systemically.
- Review concurrent corticosteroids and CYP3A inhibitors.
- Not recommended for people under 18.
Contraindications and cautions
- Hypersensitivity to any active ingredient or excipient
- Tuberculous, fungal or most viral lesions, including herpes simplex, vaccinia and varicella
- Pregnancy or breastfeeding under the selected product licences
Monitoring
- Clinical response, worsening or recurrence
- Rectal bleeding or evidence of another diagnosis
- Local sensitisation, infection or skin atrophy
- Systemic corticosteroid effects where exposure or interaction risk is increased
- Blurred vision or other visual disturbance
Clinical pharmacology
Hydrocortisone acetate provides local anti-inflammatory activity. Zinc oxide and bismuth salts protect raw surfaces and are mildly astringent. Balsam Peru is protective and mildly antiseptic; benzyl benzoate supports solubilisation and preservation. Rectal hydrocortisone absorption can occur, while the other ingredients principally act locally.
Formulation and product differences
- Suppositories are for internal haemorrhoids and contain a hard-fat base with light kaolin.
- Ointment treats internal or external symptoms and includes a rectal nozzle and anhydrous lanolin.
- The suppository is listed as a pharmacy medicine; the selected ointment is prescription-only.
balsam peru + benzyl benzoate + bismuth oxide + bismuth subgallate + hydrocortisone acetate + zinc oxide interactions
Tell a pharmacist or prescriber about other medicines, including products applied to the skin or rectum.
Other corticosteroids
Concurrent oral or topical corticosteroids may increase systemic corticosteroid effects.
Strong CYP3A inhibitors, including cobicistat-containing medicines
These can increase hydrocortisone exposure and systemic corticosteroid effects; combined use requires clinical review and, if unavoidable, monitoring.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.